New Fish Peptide Isolate FPI improves feed conversion in poultry & aquaculture

PRLog (Press Release) - Sep 15, 2009 -
PerfectDigest TM  Peptides




Bluewave Marine IngredientsTM  (www.BluewavePeru.com)  is pleased to announce the successful startup of a “first of a kind” Fish Peptide Isolate (FPi) production plant in Manta, Ecuador.  The $2MM+ project is a joint venture between Marine Protein S.A.C. of Manta, Ecuador and Bluewave Management, Inc. of Panama.   The JV is structured whereby Bluewave will manage IP and control product formulations, process development and sales/marketing of the Fish Peptide/Peptone products, while Marine Protein SAC will operate the plant and manage local logistics / raw material contracts.

The sanitary grade facility began commercial scale production of Peptides this summer with Ecuadorian poultry/aquaculture clients being the first to incorporate PerfectDigestTM FPi into their feed formulas. Inclusion rates of 0.5-1.0% during the first 2-4 weeks of feeding has resulted in Feed Conversion Rate (FCR) improvements of several percentage points for poultry.  These results have prompted additional local poultry/shrimp/tilapia feed manufacturers and farm operators to initiate trials to determine efficacy in their own applications as well.  

Luis Daqui, the Sr. Nutritionist for AgriPac / Balanfarina Feed company of Guayaquil shares that, "the initial inclusions have shown a catalytic affect of the Fish Peptide by helping the chick's digestive tract to develop and to better convert all the other feed which is consumed. About 50g of dry matter FPi has been enough to improve FCR by several points and finish weights by more than 100g". Balanfarina is now incorporating FPi/FPC into their Poultry & Aqua Feeds with finished product available for export.    ldaqui@agripac.com.ec   www.agripac.com.ec

Poultry operations see a reduction in total feed consumed to offset the Peptide inclusion (which is about 6-8 cents per chick) and then above that they are seeing animals reach larger harvest weights in fewer days.  In total, the first two applications have averaged about 300% ROI (18 cents/bird) when including the Fish Peptide Isolates.  The ease with which FCR improvements were demonstrated by local poultry producers drove the fast adoption rates in that segment, however AquaCulture and Swine benefit similarly.  

From Mark Rottmann, COO – “The Bluewave process is unique in that it utilizes patent protected membrane technology and can produce highly purified peptide isolates (with zero fat content) something which no other company is currently doing in the Americas…our plants are actually capable of producing human grade protein products as well”.  The Ecuador site is currently capable of producing about 600 tons/year of the Peptide product with plans to double capacity in the near future and Bluewave’s Pisco, Peru plant with 3,000+ tons of capacity is expected to come on line in the first half of 2010. Discussions for JV sites in Asia & Africa are underway as well.
All of the Bluewave plants are based on marine raw materials which qualify as “Sustainable”, as such the products can prove critical to AquaCulture companies needing to reduce the use of wild-catch fishmeal in their feed formulas.


For more information visit the company website.  www.BluewavePeru.com